Observations from the recent FDA Circulatory System Devices Panel meeting on bioresorbable vascular scaffolds — Patrick W. Serruys (2016) | RDL Network
A cardiologist recounts attending a 1994 FDA panel meeting where data on early coronary stent trials was presented and a bioresorbable scaffold was approved based on randomized evidence and input from patients and physicians.
Carlos M. Campos, Yao‐Jun Zhang, Christos V. Bourantas, Takashi Muramatsu, Héctor M. García‐García, Pedro A. Lemos, Javaid Iqbal, Yoshinobu Onuma, Patrick W. Serruys
Carlos Collet, Bernard Chevalier, Ángel Cequier, Jean Fajadet, Marcello Dominici, Steffen Helqvist, Ad J. van Boven, Dariusz Dudek, Dougal McClean, Manuel Almeida, Jan J. Piek, Erhan Tenekecioğlu, Antonio L. Bartorelli, Stephan Windecker, Patrick W. Serruys, Yoshinobu Onuma
Yohei Sotomi, Yosuke Miyazaki, Carlos Collet, Taku Asano, Pannipa Suwannasom, Jan Tijssen, Robbert J. de Winter, Ron Waksman, Michael J. Lipinski, Yoshinobu Onuma, Patrick W. Serruys
Josep Gómez‐Lara, Héctor M. García‐García, Yoshinobu Onuma, Scot Garg, Evelyn Regar, Bernard De Bruyne, Stefan Windecker, Dougal McClean, Leif Thuesen, Dariusz Dudek, Jacques Koolen, Robert Whitbourn, Pieter C. Smits, Bernard Chevalier, Cécile Dorange, Susan Veldhof, Marie-Angèle Morel, Ton de Vries, John A. Ormiston, Patrick W. Serruys
Discussion(0)
No comments yet. Be the first to comment.